SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-22-013718
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:56
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 hgen-20220930.htm   iXBRL 10-Q 502990
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7343
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7330
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 3636
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 3829
11 GRAPHIC chart.jpg GRAPHIC 122148
  Complete submission text file 0001214659-22-013718.txt   2907807

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hgen-20220930.xsd EX-101.SCH 34284
7 XBRL CALCULATION FILE hgen-20220930_cal.xml EX-101.CAL 16771
8 XBRL DEFINITION FILE hgen-20220930_def.xml EX-101.DEF 137197
9 XBRL LABEL FILE hgen-20220930_lab.xml EX-101.LAB 274104
10 XBRL PRESENTATION FILE hgen-20220930_pre.xml EX-101.PRE 146450
44 EXTRACTED XBRL INSTANCE DOCUMENT hgen-20220930_htm.xml XML 191611
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 221385911
SIC: 2834 Pharmaceutical Preparations